A phase II trial of inecalcitol in patients with moderate-to-severe psoriasis.
Latest Information Update: 06 Dec 2023
At a glance
- Drugs Inecalcitol (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 04 Jun 2012 Interim results were reported in a Hybrigenics media release.
- 27 Feb 2012 Planned End Date changed from 1 Oct 2012 to 1 Jun 2012, according to a Hybrigenics media release.
- 19 Dec 2011 Status changed from recruiting to active, no longer recruiting.